SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2009-10-08
Target enrollment:
Participant gender:
Summary
To evaluate SUN11031 for subcutaneous injection compared to placebo in subjects with cachexia
associated with Chronic Obstructive Pulmonary Disease (COPD) to determine the effect on
physical performance and body composition.